Table 4.
Biomarkers used to diagnose different stages of cancers (Cervical cancer).
| Biomarker | Normal | CIN1 | CIN2 | CIN3 | I | II | III | IV | Ref |
|---|---|---|---|---|---|---|---|---|---|
| MiB-1 | 10%> | >10% | - | - | >71% | >I | >II,I | High | [140] |
| CDC6 | 90% | 38% | - | 24% | - | - | 70% | - | [141] |
| CD44 | - | - | - | - | High | <I | <I,II | <I,II,III | [142] |
| CK7 | Positive | - | - | - | - | - | negative | Negative | [143] |
| hMSH2 | - | - | - | - | - | - | 54.3% | - | [71] |
| Ki-67 | 20%> | 22.6% | 82.1% | 88.6% | - | - | 100% | - | [144] |
| p16 | >10% | 10.4% | 84.5% | 90.5% | - | - | 91.3% | - | [144] |
| SSC-Ag | - | - | - | - | 24% | 53% | 75% | 90% | [145] |
| MCM3 | negative | 4–6% | - | - | - | - | 18% | - | [141] |
| p63 | 100% | 100% | - | - | 30% | - | - | 10% | [146] |
| p53 | <10% | 10% | 50% | 71% | - | - | - | - | [146] |